QA: Aquestive Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001398733_2023_Aquestive_Therapeutics_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001398733, Aquestive Therapeutics Inc.

  xvar xval
0 AssetsCurrent 39,888,000
1 IntangibleAssetsNetIncludingGoodwill 1,435,000
2 PropertyPlantAndEquipmentNet 4,085,000
3 remainder_Assets 11,662,000
4 LiabilitiesCurrent 39,528,000
5 LiabilitiesNoncurrent 38,536,000
6 remainder_Liabilities 97,560,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 52,879,000
9 ResearchAndDevelopmentExpense 17,481,000
10 remainder_Expenses 31,829,000
11 remainder_Revenues 47,779,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 57,070,000
1 Liabilities 175,624,000
2 Expenses 102,189,000
3 Revenues 47,779,000
4 StockholdersEquity -118,554,000
5 NetIncome -54,410,000
6 ComprehensiveNetIncome -54,410,000
7 BaseVar 191,331,000
8 EconomicCapitalRatio -2.22

Edgar->Model Mapping

Feature Distribution

Change over Time